Highlights,Institutional firms have adjusted their holdings in Sensus Healthcare, reflecting ongoing market activity.,The ...

Chimerix’s lead clinical pipeline candidate is dordaviprone, a first-in-class small molecule treatment designed to selectively target the mitochondrial protease ClpP and dopamine receptor D2 (DRD2).

With global cancer incidence rising and a strong clinical pipeline exploring combination therapies, the XPOVIO addressable market is expandin ...

Raw meats can be irradiated, which is a process that is used to kill pathogens, but is safe for consumption, and marked with ...